Diaverum’s €900m refi loan still in the works

Diaverum, the Swedish dialysis clinic operator, is making slow progress on a planned €900m refinancing loan. The launch is not expected until at least March.

  • By Olivier Holmey
  • 14 Feb 2014

There has been talk of the deal at least since early January, but one senior source said the plans had hardly progressed since then.

JP Morgan, which is involved in the deal, was reportedly hired over a year ago by the company’s private equity owner Bridgepoint to review ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 16 Jan 2017
1 JPMorgan 19,492.11 46 8.85%
2 UniCredit 18,866.65 83 8.57%
3 HSBC 16,021.11 53 7.27%
4 BNP Paribas 13,314.73 89 6.05%
5 Credit Suisse 13,152.31 32 5.97%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 NatWest Markets 216.56 3 8.11%
2 BNP Paribas 201.55 3 7.54%
3 HSBC 199.05 3 7.45%
3 Credit Suisse 199.05 3 7.45%
5 UniCredit 155.26 2 5.81%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 10 Jan 2017
1 JPMorgan 297.36 3 36.61%
2 RBC Capital Markets 85.86 2 10.57%
3 Wells Fargo Securities 85.71 1 10.55%
3 Mizuho 85.71 1 10.55%
3 Goldman Sachs 85.71 1 10.55%